<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Cybin’s Promising Clinical Progress and Strong Financial Position Justify Buy Rating

PremiumRatings

2d ago

Cybin price target lowered to $70 from $73 at Canaccord

PremiumThe Fly

3d ago

Cybin Inc. Reports on Governance and Compliance

PremiumCompany Announcements

3d ago

Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results

PremiumThe Fly

8d ago

PremiumRatingsCybin’s Strong Position in Psychedelic Neuropsychiatry: Buy Rating Backed by Advancements and Financial Flexibility

8d ago

Cybin Inc. Advances Mental Health Innovations with Strategic Partnerships and Clinical Progress

Company Announcements

Cybin Inc. Advances Mental Health Innovations with Strategic Partnerships and Clinical Progress

10d ago

Cybin offers up to $500M in convertible debentures

The Fly

Cybin offers up to $500M in convertible debentures

10d ago

Cybin Secures $500 Million Financing to Boost Clinical Programs

PremiumCompany Announcements

10d ago

Mike Davis to become CDER deputy director, Pink Sheet’s Gingery says

PremiumThe Fly

17d ago

CYBN Earnings this Week: How Will it Perform?

PremiumPre-Earnings

18d ago

Trump Trade: President said to weigh possible U.S. strike against Iran

PremiumThe Fly

23d ago

PremiumThe FlyPsychedelic advocates hopeful Trump administration will support space, STAT says

23d ago

Cybin Advances Phase 3 Program Amid Positive Regulatory Signals

Company Announcements

Cybin Advances Phase 3 Program Amid Positive Regulatory Signals

28d ago

Psychedelic: Clearmind engages government, political affairs consulting firm

The Fly

Psychedelic: Clearmind engages government, political affairs consulting firm

29d ago

Cybin CEO to Present at Neuro Perspectives Conference

PremiumCompany Announcements

29d ago

Cybin CEO to Speak at Psychedelic Science 2025 Conference

PremiumCompany Announcements

30d ago

Cybin initiated with a Buy at Lucid Capital

PremiumThe Fly

1M ago

Psychedelic: atai, Beckly Psytech to combine in all-share transaction

PremiumThe Fly

1M ago

PremiumCompany AnnouncementsCybin Secures U.S. Patent for CYB004 Program in Anxiety Disorder Treatment

1M ago

Cybin announces additional U.S. patent supporting CYB004

The Fly

Cybin announces additional U.S. patent supporting CYB004

1M ago

Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat

Company Announcements

Cybin CEO to Discuss Strategic Advances at Upcoming Fireside Chat

2M ago